Abivax Receives Clearance from U.S. FDA to Initiate Clinical Trials with ABX464 to treat Moderate to Severe Ulcerative Colitis

DGAPNews ABIVAX Key words Study20.01.2020 1837 The issuer is solely responsible for the content of this announcement.Abivax Receives Clearance from U.S. FDA to Initiate Clinical Trials with ABX464 to treat Moderate to Severe Ulcerative Colitis Active U....